Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14471012Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2025
Linked Award Amount
$2.1M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#6,089
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Anthony D Saleh as a PI. Multi-PI records show the full award amount for context.
- 5R44NS119147-04R44A Novel RNA Therapeutics Platform to Treat Facioscapulohumeral Muscular Dystrophy and other Neuromuscular Disorders$1.2Maward amount
- 5R44CA291527-02R44Development of an antibody-oligonucleotide conjugate for treatment of Head and Neck Squamous Cell Carcinoma$896.9Kaward amount
Award organization
Organizations that administered FY2025 awards listing Anthony D Saleh as a PI.
FY2025 award administered by Mirecule, Inc. (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMirecule, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5211